AmeriCares and Baxter International Inc. have teamed to deliver additional lifesaving intravenous (IV) solutions to Haiti as part of their ongoing effort to stem the cholera outbreak. AmeriCares has been working around the clock to distribute IV solutions, oral rehydration salts, antibiotics, hand sanitizers and other critical aid since the outbreak was reported in October. As a leading manufacturer of products used in the delivery of fluids and drugs to patients, Baxter's donations have been an integral part of the response. AmeriCares airlifted an additional 50,000 pounds of aid over the weekend which will be used to re-supply depleted stocks at cholera treatment centers and hospitals in Port-au-Prince.
Baxter has donated IV rehydration solutions and IV sets to administer the solutions that will help to bring lifesaving aid to at least 25,000 patients suffering in Haiti. Baxter has teamed with AmeriCares for nearly 25 years to share its innovative products and treatments with people in need throughout the world and has an ongoing commitment to work with AmeriCares to meet the needs of Haiti. Recently, Baxter has pre-positioned medicines and solutions in the AmeriCares warehouse, ready to be mobilized in the event of an emergency such as this cholera outbreak.
"It is estimated that more than 300,000 people will be hospitalized with cholera in the next six to eight months. This donation from Baxter is essential to getting ahead of this deadly, but treatable, disease," says Curt Welling, president and CEO of AmeriCares. "AmeriCares has worked closely with Baxter since 1987, responding to health care needs around the world. They have been generous with their products and understand the value of providing lifesaving aid to the world's most vulnerable populations."
By working together, AmeriCares and Baxter will not only help treat patients currently suffering from cholera, but will pre-position critical aid so it is ready to be delivered directly into the hands of health care professionals treating people newly diagnosed. In one month alone, 15,000 Haitians have been hospitalized for cholera. For those with acute cholera, it requires eight liters of IV solution to rehydrate and save their life. Without proper rehydration, patients can die within 10 to 12 hours if not treated right away.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.